Oral Melatonin in Critically Ill High-risk Patients
NCT00470821
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
96
Enrollment
OTHER
Sponsor class
Conditions
Critically Ill Patients
Mechanically Ventilated Patients
Interventions
DRUG:
Oral melatonin 3mg BID
DRUG:
Placebo
Sponsor
University of Milan